AU2003300870A8 - Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same - Google Patents

Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same

Info

Publication number
AU2003300870A8
AU2003300870A8 AU2003300870A AU2003300870A AU2003300870A8 AU 2003300870 A8 AU2003300870 A8 AU 2003300870A8 AU 2003300870 A AU2003300870 A AU 2003300870A AU 2003300870 A AU2003300870 A AU 2003300870A AU 2003300870 A8 AU2003300870 A8 AU 2003300870A8
Authority
AU
Australia
Prior art keywords
polypeptides
methods
same
immunodeficiency virus
human immunodeficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003300870A
Other versions
AU2003300870A1 (en
Inventor
Ian Wilson
Dennis R Burton
Ralph Pantophlet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU2003300870A8 publication Critical patent/AU2003300870A8/en
Publication of AU2003300870A1 publication Critical patent/AU2003300870A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003300870A 2002-12-11 2003-12-11 Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same Abandoned AU2003300870A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US43286902P 2002-12-11 2002-12-11
US60/432,869 2002-12-11
US46535003P 2003-04-24 2003-04-24
US60/465,350 2003-04-24
PCT/US2003/039534 WO2004053100A2 (en) 2002-12-11 2003-12-11 Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same

Publications (2)

Publication Number Publication Date
AU2003300870A8 true AU2003300870A8 (en) 2004-06-30
AU2003300870A1 AU2003300870A1 (en) 2004-06-30

Family

ID=32511677

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003300870A Abandoned AU2003300870A1 (en) 2002-12-11 2003-12-11 Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same

Country Status (2)

Country Link
AU (1) AU2003300870A1 (en)
WO (1) WO2004053100A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1868652A2 (en) * 2005-04-05 2007-12-26 Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. Method for shielding functional sites or epitopes on proteins
WO2011028963A2 (en) * 2009-09-03 2011-03-10 Biological Mimetics, Inc. Immunogenic hiv composition
WO2014022475A2 (en) * 2012-08-03 2014-02-06 Dana-Faber Cancer Institute, Inc. Compositions and methods for conformationally stabilizing primate immunodeficiency virus envelope glycoprotein trimers
EP2981545A4 (en) * 2013-04-02 2016-11-16 Univ Duke Recombinant production of hiv-1 envelope glycoproteins
US10245313B2 (en) * 2014-10-24 2019-04-02 Versitech Limited DNA motif compounds and methods for inducing specific antibodies and cellular immunity
AU2019368218A1 (en) * 2018-10-22 2021-05-27 New York University Recombinant GP120 protein with V1-loop deletion
CN117568404B (en) * 2024-01-16 2024-03-15 四川大学华西医院 Multi-finger (toe) related gene segment, animal model construction method and application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002568A1 (en) * 1988-09-13 1990-03-22 Chiron Corporation Hiv-1 envelope muteins lacking hypervariable domains
US5614612A (en) * 1990-03-09 1997-03-25 Haigwood; Nancy L. Purified gp120 compositions retaining natural conformation
US6103238A (en) * 1992-03-13 2000-08-15 President And Fellows Of Harvard College Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines
US5652138A (en) * 1992-09-30 1997-07-29 The Scripps Research Institute Human neutralizing monoclonal antibodies to human immunodeficiency virus
US5585250A (en) * 1993-08-20 1996-12-17 The United States Of America As Represented By The Department Of Health & Human Services Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies

Also Published As

Publication number Publication date
WO2004053100A2 (en) 2004-06-24
WO2004053100A3 (en) 2004-12-29
AU2003300870A1 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
ZA200502618B (en) Human papillomavirus polypeptides and immunogenic compositions
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
IL150961A0 (en) Human immunodeficiency virus vaccine
IL158289A (en) Mercaptoacetylamide derivatives, a process for their preparation and their use as medicaments for the treatment of hypertension and chf
EP1421185A4 (en) Rapid cryobaric sterilization and vaccine preparation
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
AU2001238501A1 (en) Selective destruction of cells infected with human immunodeficiency virus
AU2003271021A1 (en) Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis b and the producing method and use thereof
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
AU2002346530A1 (en) Breathable blood and viral barrier fabric
AU2003300870A8 (en) Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same
HK1074444A1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
AU2002225509A1 (en) Production and of viruses, viral isolates and vaccines
EP1389043A4 (en) Foot and mouth disease virus vaccine
AU2003278175A1 (en) Vaccines of enhanced immunogenicity, and methods for preparing such vaccines
AP2004003081A0 (en) Immunogenic formulations of variable peptidic epitopes and for preparation thereof
AU2001270209A1 (en) Hiv-1 vaccines and screening methods therefor
GB0225502D0 (en) Therapeutic and prophylactic preparations
WO2003018610A8 (en) Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods
AU2003276159A1 (en) Immunisation against components of the human immunodeficiency virus (hiv)
AU2003240866A1 (en) Antibodies, peptides and vaccines against hiv-1 virus
AU2001290031A1 (en) Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes
AU2003255866A8 (en) Gp41 epitope and uses thereof for the treatment of hiv infections
TNSN03066A1 (en) Natural antibodies active against hiv virus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase